NKGen Biotech Inc (NKGN) Tezkor likvidlik

Ushbu NKGen Biotech, Inc. (NKGN) narxlar grafigi aktivning dinamikasini aks ettiradi, uning qiymati hozirda 0.00 darajasida turibdi. NKGen Biotech, Inc. neyron degeneratsiyasiga qarshi kurashish uchun hujayra terapiyalarini ishlab chiqadi va ALS, Parkinson va Altsgeymer kasalliklarini bir vaqtda nishonga olgan holda risklarni kamaytiradi. Operatsion barqarorlik sinovlarni tashqi CRO markazlariga autsorsing qilish orqali ta'minlanadi. Asosiy o'sish dori vositalarining miya yallig'lanishini bostirish qobiliyati va yirik sog'liqni saqlash gigantlari bilan kelishuvlarning amalga oshirilishidan kutilmoqda.

NKGen Biotech Inc (NKGN) Tezkor likvidlik koeffitsiyenti: 21.02.2024 - 15.03.2025 davri uchun

NKGen Biotech, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Narx grafigi NKGen|NKGN - Oʻrtacha prognoz narxi
- bozor kapitallashuvi tafsilotlari:
Bozor qiymati NKGen|NKGN - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar NKGen Biotech|NKGN - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati nkgenbiotech.com|NKGN - Kompaniyaning balans aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati NKGen Biotech, Inc.|NKGN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati NKGen Biotech|NKGN - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati NKGen|NKGN - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari NKGen Biotech|Tezkor likvidlik koeffitsiyenti nkgenbiotech.com
- foyda va bozor multiplikatorlari tafsilotlari:
NKGN - Sof moliyaviy natija
Kompaniyaning jamlanma tahlili:NKGen, NKGN

NKGen Biotech, Inc. (NKGN) tibbiy tadqiqotlarning global makroiqtisodiy sikllardan mustaqilligi tufayli himoya aktivining roli bilan xizmat qiladi. Ushbu ko'rsatkich kompaniyaning sekin harakatlanuvchi zaxiralarni hisobga olmagan holda, faqat naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarini to'lash qobiliyatini baholaydi. GURU.Markets platformasidagi "acid-test" likvidlik tekshiruvi tahlili biznesning haqiqiy to'lov qobiliyatini tasdiqlash imkonini beradi. Ushbu qiymatning barqarorligi bozor tebranishlari davrida emitentning yashab qolish qobiliyatini tasdiqlaydi.

NKGen Biotech, Inc. kimlar bilan raqobatlashadi

Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|Tezkor likvidlik Regencell Bioscience|Shoshilinch likvidlik koeffitsiyenti AXSM (axsome.com)|Tezkor likvidlik ACADIA Pharmaceuticals Inc. (ACAD)|Tezkor likvidlik koeffitsiyenti Xenon Pharmaceuticals Inc. (XENE)|Tezkor likvidlik koeffitsiyenti VKTX (Viking Pharma)|Kritik likvidlik Supernus Corp|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik denalitherapeutics.com|Harmony Biosciences Holdings, Inc. (HRMY) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti BHVN|Tezkor likvidlik ko‘rsatkichi AMLX|TRVI: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti PRAX|Tezkor likvidlik AVXL (anavex.com)|Tezkor likvidlik koeffitsiyenti CBLL (CeriBell)|Oraliq qoplama koeffitsiyenti Prothena Corp (PRTA)|ALEC - Tezkor likvidlik|Shoshilinch likvidlik Annexon Biosciences Inc.|OMER (omeros.com) - Tezkor likvidlik ko‘rsatkichi|NGNE: Oraliq likvidlik koeffitsiyenti|ACIU (AC Immune SA) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Voyager Therapeutics Inc VYGR|Tezkor likvidlik koeffitsiyenti NMRA|Tezkor likvidlik ko‘rsatkichi Scilex Holding Company, Inc. SCLX|Tezkor likvidlik koeffitsiyenti TVGN (Tevogen Bio Holdings)|Oraliq qoplash koeffitsiyenti ACOG|CGTX: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti IKT (Inhibikase Therapeutics Inc)|SAVA: Tezkor likvidlik koeffitsiyenti|ASRT - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Coya Therapeutics Inc|Shoshilinch likvidlik koeffitsiyenti VTGN (VistaGen Therapeutics Inc)|Tezkor likvidlik koeffitsiyenti OVID|Tezkor likvidlik ko‘rsatkichi Acumen Pharmaceuticals Inc. ABOS|CervoMed Inc - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplama koeffitsiyenti Alterity Therapeutics Ltd. (ATHE)|CLNN - Tezkor likvidlik|PEPG (PepGen Inc.) - Shoshilinch likvidlik koeffitsiyenti|Jupiter Neurosciences Inc (JUNS) - Tezkor likvidlik|Relmada Therapeutics Inc (RLMD) - Tezkor likvidlik koeffitsiyenti|ANVS (Annovis Bio Corp) - Tezkor likvidlik koeffitsiyenti|GRCE - Kritik likvidlik|Tezkor likvidlik Firefly Neuroscience, Inc (AIFF)|anewmeds.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik NeuroSense Therapeutics Ltd. NRSN|RVPH: Shoshilinch likvidlik koeffitsiyenti|MetaVia, Inc. - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik NeurAxis Inc|HSDT (heliusmedical.com) - Tezkor likvidlik ko‘rsatkichi|Passage Bio (PASG) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Neuphoria Therapeutics, Inc.|NERV: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Athira (ATHA)|ADXN - Shoshilinch likvidlik|Tezkor likvidlik Alzamend Neuro ALZN|CYCN: Shoshilinch likvidlik koeffitsiyenti|PTIX - Tezkor likvidlik|KTTA - Tezkor likvidlik koeffitsiyenti|CRGT: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik Avenue Therapeutics Inc ATXI|BCLI (Brainstorm Cell) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik caratherapeutics.com CARA|Tezkor likvidlik Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Shoshilinch likvidlik koeffitsiyenti|Intra-Cellular Therapies, Inc. - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti LBPH|Marinus Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|NRBO: Tezkor likvidlik|SAGE: Tezkor likvidlik koeffitsiyenti|SNPX - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik Trevena, Inc|Shoshilinch likvidlik Vigil Neuro VIGL|Tezkor likvidlik ko‘rsatkichi WENA (Anew Medical)|Oraliq likvidlik koeffitsiyenti CERE